found significant differences in the expression of lipopolysaccharide-binding proteins, and these proteins may be a driver of NSCLC metastasis, which can be used as potential biomarkers of NSCLC metastasis and therapeutic targets (37). Here, LBP is linked to non-small cell lung carcinoma.